Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Okawa

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 25, 1970
[Primary hyperparathyroidism]J Okawa
The British Journal of Dermatology|January 17, 2012
The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index scoreI Braunstein, R Klein, J Okawa, et al.
The British Journal of Dermatology|June 10, 2014
Improvement in the cutaneous disease activity of patients with dermatomyositis is associated with a better quality of lifeE S Robinson, R Feng, J Okawa, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|July 1, 1991
[A case report on a double chambered right ventricle (DCRV)--pre- and postoperative responses of the right ventricle to atrial pacing and the isoproterenol tolerance test]F Nomura, J C Chang, J Okawa, et al.
The British Journal of Dermatology|October 12, 2013
The impact of skin damage due to cutaneous lupus on quality of lifeS M Verma, J Okawa, K J Propert, et al.
Cancer Research|July 15, 1996
Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resectionK Gohji, N Fujimoto, A Fujii, et al.
International Journal of Women'S Dermatology|December 14, 2017
The systemic management of cutaneous dermatomyositis: Results of a stepwise strategyC O Anyanwu, P B Chansky, R Feng, et al.
The British Journal of Dermatology|October 30, 2009
Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrumentM Yassaee, D Fiorentino, J Okawa, et al.
The British Journal of Dermatology|June 14, 2016
Clinical signs associated with an increased risk of interstitial lung disease: a retrospective study of 101 patients with dermatomyositisC C Ang, C O Anyanwu, E Robinson, et al.
The British Journal of Dermatology|May 22, 2015
Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical changeC O Anyanwu, D F Fiorentino, L Chung, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 25, 1970
[Primary hyperparathyroidism]J Okawa
The British Journal of Dermatology|January 17, 2012
The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index scoreI Braunstein, R Klein, J Okawa, et al.
The British Journal of Dermatology|June 10, 2014
Improvement in the cutaneous disease activity of patients with dermatomyositis is associated with a better quality of lifeE S Robinson, R Feng, J Okawa, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|July 1, 1991
[A case report on a double chambered right ventricle (DCRV)--pre- and postoperative responses of the right ventricle to atrial pacing and the isoproterenol tolerance test]F Nomura, J C Chang, J Okawa, et al.
The British Journal of Dermatology|October 12, 2013
The impact of skin damage due to cutaneous lupus on quality of lifeS M Verma, J Okawa, K J Propert, et al.
Cancer Research|July 15, 1996
Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resectionK Gohji, N Fujimoto, A Fujii, et al.
International Journal of Women'S Dermatology|December 14, 2017
The systemic management of cutaneous dermatomyositis: Results of a stepwise strategyC O Anyanwu, P B Chansky, R Feng, et al.
The British Journal of Dermatology|October 30, 2009
Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrumentM Yassaee, D Fiorentino, J Okawa, et al.
The British Journal of Dermatology|June 14, 2016
Clinical signs associated with an increased risk of interstitial lung disease: a retrospective study of 101 patients with dermatomyositisC C Ang, C O Anyanwu, E Robinson, et al.
The British Journal of Dermatology|May 22, 2015
Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical changeC O Anyanwu, D F Fiorentino, L Chung, et al.
Pageof 2